Status:
NOT_YET_RECRUITING
AspergillusOne-Health: Deciphering Azole Resistance in Aspergillus Fungi Using a One Health Approach
Lead Sponsor:
Nantes University Hospital
Conditions:
Aspergillus Fumigatus Infection
Eligibility:
All Genders
18-99 years
Brief Summary
During a two year prospective study onpatients from department's hospitals and centralized by the pneumology department Nantes CH,all respiratory clinical samples will be cultivated for Aspergillus is...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Patient who has given his or her consent to participate in the study
- Patient affiliated to a social security scheme
- Patient with a respiratory sample taken between 2020 and 2023 for the retrospective cohort and from 2024 for the prospective cohort in which Aspergillus has been isolated
- Patients living in the Loire Atlantique and Vendée regions
Exclusion
- Patient under guardianship or legal protection
- Patient of no fixed adress
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06532227
Start Date
September 1 2025
End Date
August 1 2028
Last Update
May 23 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.